BioSpace News Archive

It’s one of the biggest sources of anxiety when you’re on the job market: being faced with tough interview questions that you aren’t quite sure how to answer.

Bioavailability significantly higher than with oral administration

Regeneus Ltd is pleased to announce it has received a Notice of Intention to Grant a European patent covering the use of Progenza by the European Patent Office.

Sterna biologicals GmbH & Co. KG today announced that the Company will participate in the upcoming BIO-Europe® 2018 – 24th Annual International Partnering Conference taking place from November 5 to 7, 2018 in Copenhagen, Denmark.

The European Society of Medical Oncology was in full swing this weekend as multiple companies showed off mid- and late-stage assets that could change the way some patients are treated for their cancer. This morning, BioSpace takes a look at some of the announcements.

The American University Washington College of Law and the Food and Drug Law Institute hosted a conference late last week. One of the highlights was a plenary session that featured former commissioners of the U.S. Food and Drug Administration (FDA).

Abeona Therapeutics Inc. (Nasdaq: ABEO), a leading clinical-stage biopharmaceutical company focused on developing novel cell and gene therapies for life-threatening rare genetic diseases, today announced the appointment of João Siffert, M.D. as Head of Research and Development and Chief Medical Officer.

Mesothelioma is a rare cancer that develops in the lining of the lungs, abdomen, or cardiovascular cavity. A 2017 study reported that the number of people affected by this rare cancer is between 2,400 - 2,800 individuals per year in the United States alone.

Primary Endpoint was met, with rhC1INH treatment reducing neutrophil gelatinase-associated lipocalin (NGAL), a widely recognized marker of acute renal damage

The Society for Clinical Research Sites (SCRS) announced to almost 1,000 attendees at their 2018 Global Site Solutions Summit that Chattanooga Medical Research and Envision Physical Clinical Research are the respective winners of the Site Patient Recruitment Innovation Achievement (SPRIA) Award and the Site Tank Award.